The Fight Against COVID19
21.24k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The Fight Against COVID19 | +1.78% | - | - | - |
| ^GSPC | -0.01% | +0.65% | +34.91% | +4442.47% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 163.84 | - | - | 10:14 am GMT-4 | 647.06k | 7.15M | 431.46B |
| PFE | Pfizer Inc. | 39.467 | +0.05 | +0.12% | 10:14 am GMT-4 | 1.85M | 26.83M | 220.92B |
| ABBV | AbbVie Inc. | 114.4464 | -0.28 | -0.25% | 10:14 am GMT-4 | 510.03k | 6.59M | 202.14B |
| SNY | Sanofi | 52.13 | -0.49 | -0.93% | 10:14 am GMT-4 | 349.76k | 1.31M | 130.40B |
| GSK | GlaxoSmithKline plc | 39.29 | -0.49 | -1.23% | 10:14 am GMT-4 | 575.74k | 4.63M | 98.84B |
| MRNA | Moderna, Inc. | 215.6594 | +7.42 | +3.56% | 10:14 am GMT-4 | 2.25M | 9.29M | 86.59B |
| GILD | Gilead Sciences, Inc. | 67.27 | -0.08 | -0.12% | 10:14 am GMT-4 | 903.35k | 7.15M | 84.37B |
| REGN | Regeneron Pharmaceuticals, Inc. | 528.89 | -5.38 | -1.01% | 10:14 am GMT-4 | 106.64k | 813.19k | 56.35B |
| BNTX | BioNTech SE | 232.76 | +6.67 | +2.95% | 10:14 am GMT-4 | 520.18k | 3.03M | 56.22B |
| TAK | Takeda Pharmaceutical Company Limited | 16.78 | +0.05 | +0.30% | 10:14 am GMT-4 | 283.01k | 2.43M | 52.90B |
| NVAX | Novavax, Inc. | 186.8 | +5.81 | +3.21% | 10:14 am GMT-4 | 925.67k | 3.77M | 13.84B |
| VIR | Vir Biotechnology, Inc. | 49.58 | +0.47 | +0.96% | 10:14 am GMT-4 | 254.78k | 693.24k | 6.45B |
| INO | Inovio Pharmaceuticals, Inc. | 8.515 | -0.13 | -1.45% | 10:14 am GMT-4 | 463.83k | 8.30M | 1.78B |
- Editor's pickYahoo Finance Video
Delta COVID-19 variant likely to become dominant U.S. strain: Doctor
Dr. Susannah Hills, Pediatric Airway surgeon and assistant professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
- Investor's Business Daily
Dow Jones Today, Stocks Wobble Ahead Of Powell Testimony; Bitcoin Dives; Splunk, CrowdStrike Rally
CrowdStrike rallied early, and Microsoft topped a buy point on the Dow as stocks traded flat ahead of Jerome Powell's testimony.
- Motley Fool
Is This the Secret Ingredient That Could Make Moderna Shareholders Rich?
With the advances in both software and hardware, investors are recognizing that every company is a technology company. Rather than a back office function supporting a few productivity tools, technology has become a differentiator in industries that may seem to have little to do with software and semiconductors. In the biotech industry, Moderna (NASDAQ: MRNA) recognized this from the start.
